Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 3, 2014, Pages

  Zhu, Ningxia ^a   Liu, Bin ^a   Luo, Wenhong ^a   Zhang, Yingzhan ^a   Li, Hui ^a   Li, Shasha ^a   Zhou, Yingbi ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Arachidonic acid; Contraction; Diabetes; Metabolism; Thromboxane prostanoid receptors

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; CYCLOOXYGENASE 1; MUSCARINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; ACETYLCHOLINE; ENZYME INHIBITOR; MEMBRANE PROTEIN; MUSCARINIC AGENT; NITRIC OXIDE; PTGS1 PROTEIN, MOUSE; VASOCONSTRICTOR AGENT;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIABETIC HYPERTENSION; ENZYME DEFICIENCY; ENZYME INHIBITION; EVOKED RESPONSE; IN VITRO STUDY; LIPID DIET; METABOLITE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RENAL ARTERY; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; VASOCONSTRICTION; VASODILATATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DEFICIENCY; DIABETES COMPLICATIONS; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HYPERTENSION; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TIME;

6-KETOPROSTAGLANDIN F1 ALPHA; ACETYLCHOLINE; ANIMALS; AORTA, ABDOMINAL; BLOOD PRESSURE; CYCLOOXYGENASE 1; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPOPROSTENOL; HYPERTENSION; MEMBRANE PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCARINIC AGONISTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RENAL ARTERY; SIGNAL TRANSDUCTION; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84905235526     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00022.2014     Document Type: Article

References (55)

1. Aljofan M, Ding H. High glucose increases expression of cyclooxygenase-2, increases oxidative stress and decreases the generation of nitric oxide in mouse microvessel endothelial cells. J Cell Physiol 222: 669-675, 2010.
2. Bagi Z, Erdei N, Toth A, Li W, Hintze TH, Koller A, Kaley G. Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins. Arterioscler Thromb Vasc Biol 25: 1610-1616, 2005.
3. 2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition. FASEB J 20: 1352-1360, 2006.
4. Bunting S, Gryglewski R, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins 12: 897-913, 1976.
5. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli Gatti C, Joch H, Volpe M, Luscher TF. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107: 1017-1023, 2003.
6. Davidge ST. Prostaglandin H synthase and vascular function. Circ Res 89: 650-660, 2001.
7. Empen K, Lorbeer R, Völzke H, Reffelmann T, Schipf S, Nauck M, Kerner W, Wallaschofski H, Felix S, Dörr M. Do patients with type 1 and type 2 diabetes really have an impaired endothelial function? A population-based propensity score matching analysis. Cardiovasc Diabetol 12: 174, 2013.
8. Feletou M, Huang Y, Vanhoutte PM. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 164: 894-912, 2011.
9. Feletou M, Verbeuren TJ, Vanhoutte PM. Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br J Pharmacol 156: 563-574, 2009.
10. Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 146: 834-845, 2005.
11. Grosser T, Yu Y, Fitzgerald GA. Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med 61: 17-33, 2010.
12. Guo Z, Su W, Allen S, Pang H, Daugherty A, Smart E, Gong MC. COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc Res 67: 723-735, 2005.
13. Ihara E, Hirano K, Derkach DN, Nishimura J, Nawata H, Kanaide H. The mechanism of bradykinin-induced endothelium-dependent contraction and relaxation in the porcine interlobar renal artery. Br J Pharmacol 129: 943-952, 2000.
14. Imig JD. Eicosanoids and renal vascular function in diseases. Clin Sci (Lond) 111: 21-34, 2006.
15. Kassan M, Choi SK, Galan M, Bishop A, Umezawa K, Trebak M, Belmadani S, Matrougui K. Enhanced NF-B activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes. Diabetes 62: 2078-2087, 2013.
16. Kirkby NS, Lundberg MH, Harrington LS, Leadbeater PD, Milne GL, Potter CM, Al-Yamani M, Adeyemi O, Warner TD, Mitchell JA. Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system. Proc Natl Acad Sci USA 109: 17597-17602, 2012.
17. Kirkby NS, Zaiss AK, Urquhart P, Jiao J, Austin PJ, Al-Yamani M, Lundberg MH, MacKenzie LS, Warner TD, Nicolaou A, Herschman HR, Mitchell JA. LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expression. PLOS ONE 8: e69524, 2013.
18. Kosugi T, Heinig M, Nakayama T, Matsuo S, Nakagawa T. eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists. Am J Pathol 176: 619-629.
19. 2) of isolated human saphenous and rat venous tissue. Prostaglandins 16: 93-97, 1978.
20. Li M, Kuo L, Stallone JN. Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression. Am J Physiol Heart Circ Physiol 294: H2444-H2455, 2008.
21. Liu B, Luo W, Zhang Y, Li H, Zhang J, Tan XR, Zhou Y. Concomitant activation of functionally opposing prostacyclin and thromboxane prostanoid receptors by cyclo-oxygenase-1-mediated prostacyclin synthesis in mouse arteries. Exp Physiol 97: 895-904, 2012.
22. Liu B, Luo W, Zhang Y, Li H, Zhu N, Huang D, Zhou Y. Effect of celecoxib on cyclooxygenase-1-mediated prostacyclin synthesis and endothelium-dependent contraction in mouse arteries. Eur J Pharmacol 698: 354-361, 2013.
23. Liu B, Luo W, Zhang Y, Li H, Zhu N, Huang D, Zhou Y. Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries. Exp Physiol 97: 277-289, 2012.
24. Liu B, Luo W, Zhang Y, Li H, Zhu N, Huang D, Zhou Y. Role of cyclooxygenase-1-mediated prostacyclin synthesis in endothelium-dependent vasoconstrictor activity of porcine interlobular renal arteries. Am J Physiol Renal Physiol 302: F1133-F1140, 2012.
25. Liu B, Zhang Y, Zhu N, Li H, Luo W, Zhou Y. A vasoconstrictor role for cyclooxygenase-1-mediated prostacyclin synthesis in mouse renal arteries. Am J Physiol Renal Physiol 305: F1315-F1322, 2013.
26. + channels in coronary arterial smooth muscle cells in Zucker Diabetic Fatty rats. Diabetes 54: 2155-2163, 2005.
27. Luo J, Quan J, Tsai J, Hobensack CK, Sullivan C, Hector R, Reaven GM. Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism 47: 663-668, 1998.
28. Mitchell JA, Ali F, Bailey L, Moreno L, Harrington LS. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exp Physiol 93: 141-147, 2008.
29. Mitchell JA, Lucas R, Vojnovic I, Hasan K, Pepper JR, Warner TD. Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events. FASEB J 20: 2468-2475, 2006.
30. Niwa K, Haensel C, Ross ME, Iadecola C. Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ Res 88: 600-608, 2001.
31. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and-2 activity on the pressor response to angiotensin II. J Clin Invest 110: 61-69, 2002.
32. Quilley J, Chen YJ. Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney. Hypertension 42: 837-843, 2003.
33. Ramos-Alves FE, de Queiroz DB, Santos-Rocha J, Duarte GP, Xavier FE. Increased cyclooxygenase-2-derived prostanoids contributes to the hyperreactivity to noradrenaline in mesenteric resistance arteries from offspring of diabetic rats. PLOS ONE 7: e50593, 2012.
34. Rapoport RM, Williams SP. Role of prostaglandins in acetylcholineinduced contraction of aorta from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 28: 64-75, 1996.
35. Sanchez A, Contreras C, Villalba N, Martinez P, Martinez AC, Briones A, Salaices M, Garcia-Sacristan A, Hernandez M, Prieto D. Altered arachidonic acid metabolism via COX-1 and COX-2 contributes to the endothelial dysfunction of penile arteries from obese Zucker rats. Br J Pharmacol 159: 604-616, 2010.
36. Shi Y, Feletou M, Ku DD, Man RY, Vanhoutte PM. The calcium ionophore A23187 induces endothelium-dependent contractions in femoral arteries from rats with streptozotocin-induced diabetes. Br J Pharmacol 150: 624-632, 2007.
37. Shi Y, Vanhoutte PM. Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br J Pharmacol 154: 639-651, 2008.
38. Sun D, Liu H, Yan C, Jacobson A, Ojaimi C, Huang A, Kaley G. COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS knockout mice. Am J Physiol Heart Circ Physiol 291: H1429-H1435, 2006.
39. Tang EH, Ku DD, Tipoe GL, Feletou M, Man RY, Vanhoutte PM. Endothelium-dependent contractions occur in the aorta of wild-type and COX2-/-knockout but not COX1-/-knockout mice. J Cardiovasc Pharmacol 46: 761-765, 2005.
40. 2+ impairs endothelial function in renovascular hypertensive rats. Antioxid Redox Signal 16: 363-373, 2012.
41. Traupe T, Lang M, Goettsch W, Munter K, Morawietz H, Vetter W, Barton M. Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens 20: 2239-2245, 2002.
42. Vanhoutte PM. Endothelium-dependent contractions in hypertension: when prostacyclin becomes ugly. Hypertension 57: 526-531, 2011.
43. Vessieres E, Guihot AL, Toutain B, Maquigneau M, Fassot C, Loufrani L, Henrion D. COX-2-derived prostanoids and oxidative stress additionally reduce endothelium-mediated relaxation in old type 2 diabetic rats. PLOS ONE 8: e68217, 2013.
44. Virdis A, Colucci R, Neves MF, Rugani I, Aydinoglu F, Fornai M, Ippolito C, Antonioli L, Duranti E, Solini A, Bernardini N, Blandizzi C, Taddei S. Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition. Eur Heart J 33: 2225-2234.
45. Wassef L, Kelly DJ, Gilbert RE. Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes. Kidney Int 66: 1805-1814, 2004.
46. 1a receptors prevents diabetes-induced hypertension. Am J Physiol Regul Integr Comp Physiol 292: R1184-R1189, 2007.
47. 2 mediates contraction and relaxation of vascular smooth muscle. Am J Physiol Heart Circ Physiol 267: H796-H803, 1994.
48. 2 and prostacyclin. Br J Pharmacol 154: 1225-1235, 2008.
49. Yu Y, Ricciotti E, Scalia R, Tang SY, Grant G, Yu Z, Landesberg G, Crichton I, Wu W, Pure E, Funk CD, FitzGerald GA. Vascular COX-2 modulates blood pressure and thrombosis in mice. Sci Transl Med 4: 132ra154, 2012.
50. Zhao YJ, Wang J, Tod ML, Rubin LJ, Yuan XJ. Pulmonary vasoconstrictor effects of prostacyclin in rats: potential role of thromboxane receptors. J Appl Physiol (1985) 81: 2595-2603, 1996.
51. 2 receptors in isolated C57BL/6J mouse blood vessels. Am J Physiol Heart Circ Physiol 285: H2797-H2803, 2003.
52. Zhou Y, Luo W, Zhang Y, Li H, Huang D, Liu B. Cyclo-oxygenase-1 or-2-mediated metabolism of arachidonic acid in endothelium-dependent contraction of mouse arteries. Exp Physiol 98: 1225-1234, 2013.
53. Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA, Zweier JL. Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol 289: H1027-H1032, 2005.
54. Zou MH. Peroxynitrite and protein tyrosine nitration of prostacyclin synthase. Prostaglandins Other Lipid Mediat 82: 119-127, 2007.
55. 2 receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51: 198-203, 2002.